Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: A short-term, low dose, randomized, placebo-controlled study

Alfredo Carlo Altamura, Bernardo Dell'Osso, Massimiliano Buoli, Silvia Zanoni, Emanuela Mundo

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of the present study was to evaluate the efficacy of short-term low-dose intravenous augmentative citalopram (10mg/d) versus clomipramine (25 mg/d) versus placebo in a sample of patients with MDE and partial or no response to selective serotonin reuptake inhibitors (SSRIs). Fifty-four patients with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, MDE and partial or no response to SSRIs per os (21-item Hamilton Depression Rating Scale [HAM-D21] score reduction,

Original languageEnglish
Pages (from-to)406-410
Number of pages5
JournalJournal of Clinical Psychopharmacology
Volume28
Issue number4
DOIs
Publication statusPublished - Aug 2008

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: A short-term, low dose, randomized, placebo-controlled study'. Together they form a unique fingerprint.

Cite this